The expression profiles of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER2)/neu have been used for predicting the outcome and response to the therapy of breast cancer for a number of years. This evidence concerns the gene ERBB2 and breast cancer.